Siga Technologies Inc

SIGA Biotech & pharma

Sells antiviral drugs for smallpox disease.

Jun 2026Revenue $53.7M/yrExpenses $64.8M/yr
No trendCash runway ≈ 5.8 years from Jun 2026
Figures by year

When will Siga Technologies be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $53.7M and expenses $64.8M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$94.6M$70.9M$23.7M
Dec 2024$139M$68.7M$70.0M
Dec 2023$140M$56.3M$83.6M
Dec 2022$111M$68.1M$42.7M
Dec 2021$134M$44.6M$89.1M
Dec 2020$125M$40.5M$84.5M
Dec 2019$26.7M$29.1M−$2.32M
Dec 2018$477M$122M$355M
Dec 2017$12.3M$31.1M−$18.8M
Dec 2016$15.0M$46.0M−$31.0M